Novartis Investigative Site

Trivandrum, Kerala 695607

0 studies enrolling now · 5 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Chronic Heart Failure, Chronic Pain, Heart Failure With Reduced Ejection Fraction, Hepatitis C, IgA Nephropathy, Immunoglobulin A Nephropathy

Studies at this site

• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early